Literature DB >> 660204

Comparative simultaneous measurement of cerebrospinal fluid 5-hydroxyindoleacetic acid and blood serotonin levels in delirium tremens and clozapine-induced delirious reaction.

C M Banki, M Vojnik.   

Abstract

Cerebrospinal fluid 5-hydroxyindoleacetic acid and total blood serotonin levels were measured simultaneously in 11 female patients with delirium tremens and nine schizophrenic women with clozapine-induced acute delirium. Both groups had significantly raised levels of 5HIAA in CSF and significantly reduced blood 5HT levels as compared with normal control subjects, symptom-free alcoholics, or clozapine-treated schizophrenics. The two delirious groups were not distinguishable from each other in respect of their CSF 5HIAA or blood 5HT values. After clinical recovery both values returned to normal levels.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660204      PMCID: PMC493048          DOI: 10.1136/jnnp.41.5.420

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Arterial noradrenaline levels after ethanol withdrawal.

Authors:  C Carlsson; J Häggendal
Journal:  Lancet       Date:  1967-10-21       Impact factor: 79.321

2.  Changes in brain alcohol dehydrogenase activity during chronic ethanol ingestion and withdrawal.

Authors:  N H Raskin; L Sokoloff
Journal:  J Neurochem       Date:  1974-03       Impact factor: 5.372

3.  Induction of liver acetaldehyde dehydrogenase: possible role in ethanol tolerance after exposure tobarbiturates.

Authors:  G Redmond; G Cohen
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

4.  Effects of ethanol on serotonin metabolism in brain.

Authors:  B Tabakoff; W O Boggan
Journal:  J Neurochem       Date:  1974-05       Impact factor: 5.372

5.  A further insight into the metabolism of certain -carbolines.

Authors:  R M Dajani; S E Saheb
Journal:  Ann N Y Acad Sci       Date:  1973-04-30       Impact factor: 5.691

6.  Ethanol-induced sleep in relation to serotonin turnover and conversion to 5-hydroxyindoleacetaldehyde, 5-hydroxytryptophol, and 5-hyroxyindoleacetic acid.

Authors:  A Feldstein
Journal:  Ann N Y Acad Sci       Date:  1973-04-30       Impact factor: 5.691

7.  Biogenesis of biologically active alkaloids from amines by alcohol and acetaldehyde.

Authors:  M J Walsh
Journal:  Ann N Y Acad Sci       Date:  1973-04-30       Impact factor: 5.691

8.  Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders.

Authors:  C M Banki
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

9.  Effect of clozapine on 5-HIAA excretion in urine and CSF of psychotic patients and on serotonin metabolism in rat brain.

Authors:  M Ackenheil; B Blatt; C Lampart
Journal:  Acta Vitaminol Enzymol       Date:  1975

10.  Total 5-hydroxyindoles in blood related to migraine attacks.

Authors:  J R Berstad
Journal:  Acta Neurol Scand       Date:  1976-10       Impact factor: 3.209

View more
  4 in total

Review 1.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

2.  A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium.

Authors:  H J Koponen; U Lepola; E Leinonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 3.  5-HIAA as a Potential Biological Marker for Neurological and Psychiatric Disorders.

Authors:  Hridya Jayamohananan; Maneesha Kalappurackal Manoj Kumar; Aneesh T P
Journal:  Adv Pharm Bull       Date:  2019-08-01

4.  Plasma 5-HIAA activity indicative of serotonergic disturbances in cognitively impaired, elderly patients experiencing postoperative delirium.

Authors:  Annelies Heylen; Yannick Vermeiren; Sophia E De Rooij; Rikie M Scholtens; Barbara C Van Munster; Debby Van Dam; Peter P De Deyn
Journal:  Int J Geriatr Psychiatry       Date:  2022-02       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.